Evidence map›Paper›PMID 35547201›Full record

ArticleFrontiers in medicine2022

Pathology Assessments of Multiple Organs in Fatal COVID-19 in Intensive Care Unit vs. Non-intensive Care Unit Patients.

Yoann Zerbib, Nelly Guilain, Sébastien Eymieux, Rustem Uzbekov, Sandrine Castelain, Emmanuelle Blanchard, Catherine François, Denis Chatelain, Clément Brault, Julien Maizel and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Innate immune evasion strategies of SARS-CoV-2.Nature reviews. Microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Yoann ZerbibIntensive Care Unit, Amiens Picardie University Hospital, Amiens, France.
Nelly GuilainDepartment of Pathology, Amiens Picardie University Hospital, Amiens, France.
Sébastien EymieuxINSERM U1259 MAVIVH, Université de Tours and CHRU de Tours, Tours, France.
Rustem UzbekovPlate-Forme IBiSA de Microscopie Electronique, Université de Tours and CHRU de Tours, Tours, France.
Sandrine CastelainDepartment of Virology, Amiens Picardie University Hospital, Amiens, France.
Emmanuelle BlanchardINSERM U1259 MAVIVH, Université de Tours and CHRU de Tours, Tours, France.
Catherine FrançoisDepartment of Virology, Amiens Picardie University Hospital, Amiens, France.
Denis ChatelainDepartment of Pathology, Amiens Picardie University Hospital, Amiens, France.
Clément BraultIntensive Care Unit, Amiens Picardie University Hospital, Amiens, France.
Julien MaizelIntensive Care Unit, Amiens Picardie University Hospital, Amiens, France.
Philippe RoingeardINSERM U1259 MAVIVH, Université de Tours and CHRU de Tours, Tours, France.
Michel SlamaIntensive Care Unit, Amiens Picardie University Hospital, Amiens, France.
Centre Hospitalier Universitaire Amiens-Picardie · FRUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The objective of the present study was to provide a detailed histopathological description of fatal coronavirus disease 2019 (COVID 19), and compare the lesions in Intensive Care Unit (ICU) and non-ICU patients. Methods: In this prospective study we included adult patients who died in hospital after presenting with confirmed COVID-19. Multiorgan biopsies were performed. Data generated with light microscopy, transmission electron microscopy (TEM) and RT-PCR assays were reviewed. Results: 20 patients were enrolled in the study and the main pulmonary finding was alveolar damage, which was focal in 11 patients and diffuse in 8 patients. Chronic fibrotic and inflammatory lesions were observed in 18 cases, with acute inflammatory lesions in 12 cases. Diffuse lesions, collapsed alveoli and dystrophic pneumocytes were more frequent in the ICU group (62.5%, vs. 25%; 63%, vs. 55%; 87.5%, vs. 54%). Acute lesions (82%, vs. 37.5%; Conclusion: Lung injury was different in ICU and non-ICU patients. Extrapulmonary damage consisting in kidney and myocardial injury were more frequent in ICU patients. Our TEM experiments provided the first description of SARS-CoV-2-induced DMVs in kidney biopsy samples-a sign of intense viral replication in this organ.

Indexed as

ARDSCOVID-19ICUlung pathologySARS-CoV-2

Identifiers

PMID35547201
PMCPMC9081791
OpenAlexW4224322509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.